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Abstract: Oxygen plays a critical role in the perpetuation and propagation of almost all forms of life. The primary site of 
cellular oxygen consumption is the mitochondrial electron transport chain and in addition, oxygen is also used as a sub-
strate for various enzymes involved in cellular homeostasis. Although our knowledge of the biochemistry and physiology 
of oxygen transport is century old, recent development of sophisticated tools of biophysical chemistry revealed that tissue 
oxygenation and oxygen sensing is a highly evolved process, especially in mammals. Perturbation of normal oxygen sup-
ply is associated with diseases like tumorigenesis, myocardial infarction and stroke. Available information suggests that 
when tissue oxygen supply is limited, mitochondria emanate signals involving reactive oxygen species generation which 
in turn stabilizes oxygen sensing transcription factor HIF-1. Upon stabilization, HIF-1 elicits necessary genetic response 
to cope with the diminished oxygen level. In view of such critical role of HIF-1 in cellular oxygen sensing, recently there 
has been a heightened interest in understanding the biology of HIF-1 in the context of cardiovascular system. The follow-
ing review describes some of the recent advances in this regard. 
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INTRODUCTION 
  Molecular oxygen, perhaps is only second to water for its 
critical role in the sustenance and propagation of life process. 
Nevertheless, although the biochemical mechanisms of oxy-
gen transport (by hemoglobin) and its consumption in the 
mitochondria (by oxidative phosphorylation) was established 
almost half a century ago, the comprehensive understanding 
of its role in aerobic life is still emerging [1, 2]. Data accu-
mulated over the years suggest that apart from its key role in 
ATP generation, oxygen is also involved in cellular proc-
esses such as biosynthesis of sterol and prostaglandin, de-
toxification by cytochrome p-450 etc [3, 4]. In addition, cel-
lular oxygen is also attributed to the intracellular generation 
of a plethora of highly reactive molecules collectively known 
as reactive oxygen/nitrogen species (ROS/RNS) causing 
oxidative modifications of various biomolecules with diverse 
consequences [5-7]. Taken together, it is expected that oxy-
gen homeostasis, as maintained by cellular oxygen uptake 
and consumption, have profound effects on cellular wellbe-
ing [1]. Accordingly, inadequacy of oxygen supply or hy-
poxia, either to the whole body or to certain tissues has se-
vere pathological consequences such as cardiovascular dis-
eases, tumorigenesis and stroke [8].  
  Our interest in the pathobiology of hypoxia dates back to 
nineteen thirties (with first Pubmed entry in 1939) and since 
it has been one of the most extensively investigated subject 
in modern biology (with 79802 Pubmed entries till March, 
2008). However, the molecular insight into the hypoxic re-
sponse was first gained only in early nineties in the context 
of tumorigenesis, while that by the cardiovascular system| 
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came thereafter. The present review is thus aimed towards 
summarizing some of those recent observations and putting 
them in the larger context of the physiology of oxygen sens-
ing by the myocardium.  
A. Tissue Oxygen Level and Oxygen Sensing 
  Mammalian tissues are characterized by aerobic metabo-
lism and require uninterrupted oxygen supply. Accordingly, 
availability (or otherwise) of oxygen in tissues play a critical 
role in the pathophysiology of the organism [9]. However, 
precise measurement of oxygen levels in various organs is a 
challenging task and our understanding of tissue oxygen lev-
els is still inadequate [10]. Available data also suggests that 
partial pressure of oxygen in various tissues might vary sig-
nificantly. According to one study in rat, oxygen tension is 
highest in the bladder (~ 60 mmHg), followed by muscle 
(~40 mmHg), liver (~20 mmHg), and renal cortex (~ 15 
mmHg) [9]. Since the availability and consumption of oxy-
gen in various tissues may vary under different pathophysi-
ological conditions, the respiratory process involving the 
heart, lung and the brain finely tunes the supply and demand 
of tissue oxygen while failure in such regulation leads to 
hypoxia (or hyperoxia). Hypoxic condition may arise under a 
number of conditions such as low partial pressure of oxygen 
in arterial blood (as in case of pulmonary diseases or high 
altitudes); reduced ability of the blood to carry oxygen (as in 
case of anemia); reduced tissue perfusion of oxygen (as in 
case of ischemia) and altered geometry of the tissue and the 
microvessels (as in case of tumors) [11]. Taken together, it is 
thus imperative that mammalian cells have acquired an 
elaborate mechanism to sense tissue oxygen supply and take 
remedial measures under hypoxia or heperoxia.  
  At the organismal level, oxygen sensing is done by the 
carotid body, located along with the carotid artery that sup-
plies freshly oxygenated blood to the brain. Glomus cells of 266    Current Cardiology Reviews, 2010, Vol. 6, No. 4  Goswami and Das 
the carotid body senses diminished oxygen supply and re-
lease dopamine. Dopamine then activates the sensory neu-
rons, initiating a series of responses by the respiratory and 
cardiovascular system ensuring adequate oxygenation of all 
the organs [12]. Mechanisms of oxygen sensing by the indi-
vidual tissues and cells are more diverse and are often de-
bated [13]. Diverse types of proteins/enzymes like potassium 
channels, mitochondrial complex III and IV, NADPH oxi-
dases, prolyl hydroxylases and heme oxygenases have been 
described as oxygen sensors in various cellular contexts [14]. 
Oxygen sensitive potassium channels are found in carotid 
body, lung, adrenal medulla and smooth muscle cells [15-
17]. However, in spite of convincing evidences about their 
oxygen sensing functions, it has also been argued that potas-
sium channels are not the “oxygen sensors” as such, but are 
coupled to some other sensing molecules located in the 
plasma membrane [18-20]. In this context, intracellular reac-
tive oxygen species generation that depends upon the state of 
oxygenation, have often been considered as the oxygen sen-
sors for potassium channels and other oxygen sensitive 
pathways [20, 21]. A number of hypoxia sensitive channels 
including IKs have been identified in cardiac myocytes [21]. 
Oxygen level and the duration of hypoxia play critical roles 
in determining responses elicited by the cardiac channels. 
However, many cardiac ion channels do not respond to hy-
poxia [21].  
B. Oxygen Sensing in Heart and Flow Regulation 
  Mammalian heart is an obligatory aerobic organ consum-
ing large amount of oxygen for energy generation and con-
tractile functions [22]. The rate of oxygen utilization by the 
myocardium further increases upon vigorous exercise. Heart 
also requires oxygen for synthesizing certain regulatory 
molecules like nitric oxide and other reactive species playing 
critical roles in cardiovascular biology. Cardiac function is 
thus severely impaired upon limiting (as well as surplus) 
oxygen supply and cardiologists have been looking for a 
comprehensive understanding of the delivery of oxygen to 
the myocardium [23]. Coronary vasculature plays an impor-
tant role in myocardial oxygen sensing. Decrease in arterial 
oxygen content (or increase in myocardial work load) is im-
mediately sensed by the smooth muscle cells in the vessel 
wall resulting in an instantaneous increase in coronary flow, 
ensuring adequate oxygen supply [24]. Available evidences 
suggest that even slight changes in coronary oxygen level 
leads to altered energy metabolism, which in turn modulate 
coronary tone/flow in a complex manner [25]. Furthermore, 
although reduction in oxygen concentration results in a de-
crease in the respiratory rate and [ATP]/[ADP] ratio; even at 
low O2 tensions, the mitochondrial respiratory chain remains 
at near equilibrium with the ATP synthesizing reactions [26, 
27]. Thus, metabolic pathways play a role in tissue oxygen 
sensing and limited oxygen supply affects cellular metabo-
lism much before it affects respiration. A number of metabo-
lites have thus been investigated for their crucial roles in 
vascular oxygen sensing and flow regulation. When rat heart 
coronary vessel preparations are exposed to hypoxia, vessels 
surrounded by myocardial tissues are dilated to a greater 
extent than those which are stripped [28]. Available evi-
dences suggest that under hypoxic condition, endothelial   
 
cells produce prostaglandin followed by vasorelaxation [29, 
30]. Hypercapnic acidosis, a condition arising due to the 
accumulation of carbon dioxide-decrease in pH due to re-
duced oxygen supply, has also been attributed to the regula-
tion of coronary flow while nitric oxide, adenosine and KATP 
channels have been coined as possible mediators [31, 32]. 
However, whether or not those metabolites play a universal 
role in arterial oxygen sensing under different physiologi-
cal/experimental conditions is a subject of intense debate 
[24].  
C. Myocardial Response to Hypoxia 
  Myocardium might undergoes hypoxia (or anoxia) under 
a number of pathophysiological conditions like coronary 
artery occlusion, anemia and at high altitude [22, 23]. Also, 
under hypoxic conditions, the availability of oxygen in vari-
ous parts of the myocardium might remain uneven [33]. Due 
to the criticality of oxygen supply, cardiac cells afflicted by 
mild hypoxia often readjust their oxygen sensing “set point” 
while restoration of normal oxygen level results in a condi-
tion termed as “perceived hyperoxia” [23]. Cardiac response 
to diminished oxygen supply thus depends upon its extent, 
duration, as well as other associated factors (such as ische-
mia); while measurable reduction in the cellular oxygen 
utilization (by cytochrome c oxidase) occurs only upon sub-
stantial depletion of oxygen supply [34-38]. During the past 
decades, investigators have used different experimental set-
tings and diverse biochemical-molecular markers to under-
stand the effects of hypoxia on the cardiovascular system 
and thus had accumulated wealth of information in this re-
gard. Studies with cultured myocytes have shown that hy-
poxia induces endoplasmic reticulum stress wherein AMP-
Kinase play a protective role [39, 40]. Also in hypoxic myo-
cytes, induction of adrenomedullin (pro-survival peptide 
hormone), Akt (pro-survival kinase), BNip3 (pro-death BH3 
domain containing protein) and Gene 33/RALT (pro-death 
adapter protein) have been reported [41-44]. In contrast to 
cultured myocytes, studies with whole heart either ex vivo or 
in vivo had shown divergent and often conflicting results. 
Mice undergoing acclimatization to long term normobaric 
hypoxia (10% O2) expressed heme oxygenase 1/2 in the 
heart, while those undergoing short term acute hypobaric 
hypoxia (426 mm Hg) showed altered expression of both 
pro- and anti oxidant genes [45, 46]. According to one study, 
adult male rats exposed to 10% inspired O2 (daily 6 hours) 
showed cardioprotection (via augmentation of RyR and 
NCX) when isolated perfused hearts were subjected to I/R 
[47]. On the contrary, intermittent hypoxia (5% inspired 
oxygen for 40 sec followed by infusion of compressed air for 
20 sec) for four hours increased sensitivity to reperfusion 
injury that was preventable by recombinant erythropoietin 
[48]. In a more elaborate study, where rats were subjected to 
brief ischemia by coronary ligation showed differential regu-
lation of battery of genes viz., BNP, HIF-1, IL-6, iNOS, IGF, 
Prepro-endothelin-1, sarcoplasmic reticulum Ca2+ ATPase, 
phospholamban and Na+-Ca2+ exchanger etc., in the left and 
right ventricle [49]. Taken together, depending upon of mode 
and duration of hypoxia, myocardial response could be com-
plex and involve integration of multiple signaling pathways 
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D. Mitochondria and Cellular Oxygen Sensing 
  Mitochondria is the primary site for cellular oxygen con-
sumption wherein it binds to cytochrome oxidase and re-
ceives electrons from reduced cytochrome c. Constituents of 
electron transport chain in general and cytochrome oxidase 
in particular have thus been critically examined for their po-
tential role(s) in oxygen sensing, albeit with conflicting in-
ferences [52]. Early studies had shown that the pO2 required 
for half-maximal reduction of cytochrome c can be as low as 
0.2-0.02 Torr, thereby making it more suited for sensing an-
oxia rather than hypoxia [53,54]. In agreement, it has also 
been observed that inhibition of oxidative phosphorylation 
(and thus of cytochrome c) by cyanide and antimycin does 
not affect the hypoxic induction of erythropoietin mRNA 
[55]. On the contrary, it has also been demonstrated that un-
der prolonged hypoxia, the catalytic activity of cytochrome c 
oxidase is inhibited by an allosteric mechanism, thereby 
supporting the notion that it is an oxygen sensor [56, 57]. 
Thus, in spite of an early consensus on the criticality of mi-
tochondria in oxygen/hypoxic sensing, the precise nature of 
the sensor (and its mechanism of action) remained elusive 
for quite sometimes. The criticality of mitochondria in elicit-
ing hypoxic response was further revealed upon demonstra-
tion that it requires intact mitochondrial genome and in-
volves reactive oxygen species generation [58-60]. Although 
the essentiality of intact mitochondrial electron transport 
chain in hypoxic sensing has since been disputed [61, 62], 
possible explanation against such discrepant observations 
has also been offered [63]. Taken together, the mechanism(s) 
of oxygen sensing by mitochondria is yet to be fully under-
stood. However, as discussed below, studies over the past 
decade have convincingly established the existence of an 
axis of mitochondrial reactive oxygen species generation and 
hypoxic response.  
E. Mitochondrial Reactive Oxygen Species Generation 
and Cardiovascular Diseases  
  Mitochondrial electron transport chain is a complex as-
sembly redox-proteins engaged in transfer of electrons from 
NADH/FADH2 to molecular oxygen, thereby generating an 
electrochemical gradient ( pH and m) across the inner 
mitochondrial membrane driving ATP synthesis. Although 
such transfer of electrons is highly efficient and well coordi-
nated, a small proportion of oxygen is partially reduced to 
superoxide ion (O2
.) in this process [64]. Superoxide produc-
tion is further augmented by the phosphorylation of electron 
transport proteins under certain pathophysiological condi-
tions [65, 66]. Superoxide is a highly reactive species and as 
a remedial measure, mitochondria also contain superoxide 
dismutase that converts it into H2O2, its less reactive coun-
terpart [67]. Components of the electron transport chain con-
tribute towards ROS generation under different metabolic 
and pathophysiological contexts [68]. In post-ischemic heart, 
generation of superoxide causes decreased S-glutathiony-
lation and electron transport activity of Complex II, resulting 
in mitochondrial dysfunction [69]. Following ischemia-
reperfusion, enhanced ROS generation in mitochondria re-
sults in thiol modifications in Complex I followed by respi-
ratory dysfunction [70] Right ventricular heart failure in-
duced by pulmonary arterial hypertension is associated with 
an increased generation of ROS by NADPH oxidase and 
mitochondrial complex II [71]. In agreement with the delete-
rious consequences of mitochondrial ROS generation, reduc-
tion in oxidative stress by calorie restriction or over expres-
sion of catalase augments cardiac performance [72, 73]. 
F. HIF-1 and Oxygen Sensing 
  Due to the essentiality of aerobic metabolism and differ-
ential oxygenation of tissues, mammals have a highly sensi-
tive mechanism of adapting to altered tissue oxygen level [7, 
23, 24]. Thus in addition to the immediate systemic response 
to hypoxia (as discussed above), all mammalian cells also 
undergo a long term adaptation by reprogramming its gene 
expression, hallmark of which is the enhancement of Hy-
poxia inducible factor-1 or HIF-1 activity [74-76]. Origi-
nally, HIF-1 was identified as the activator of erythropoietin 
gene transcription under hypoxic condition [77, 78]. It is a 
heterodimeric transcription factor comprising of two poly-
peptide subunits i.e.,  and . While the  subunits have mul-
tiple variants generated from three different genes, the  
subunit is ubiquitously expressed [79]. HIF-1 elicits hypoxic 
response through the hypoxia response element (HRE) lo-
cated in the regulatory regions of hypoxia responsive genes. 
Recent data suggests that HIF-1 up- and down regulate sev-
eral hundred human genes involved in anaerobic glycolysis, 
tissue oxygenation, vasodialation etc [80]. Although HIF-1 
can also be activated by stimuli other than hypoxia; over the 
years its activation has evolved as a paradigm of hypoxic 
signaling under various pathophysiological contexts [74-76, 
79, 80].  
G. Mitochondrial Reactive Oxygen Species Generation 
and Activation of HIF-1  
  Although the role of mitochondrial reactive oxygen spe-
cies in the activation of HIF-1 was first revealed in late nine-
ties, the precise connection between the two processes had 
often been debated [81-86]. Nevertheless, three recent stud-
ies using tools of (a) RNAi to suppress expression of the 
constituents of mitochondrial complex III, (b) novel ROS-
sensitive FRET probe and (c) murine embryonic cells lack-
ing cytochrome c; have convincingly established the cellular 
oxygen levels-mitochondrial ROS generation-HIF-1 axis 
[63, 87-90].  
  Although intracellular generation of ROS/RNS has long 
been considered to be deleterious for proteins and other mac-
romolecules; their apparent roles in cell signaling had subse-
quently resulted in a paradigm shift in redox biology [91-94]. 
It now appears that ROS/RNS might cause momentary but 
specific modifications of amino acid side chains, thereby 
imparting molecular switches modulating their functions [95, 
96]. Generation of ROS/RNS has accordingly been attributed 
to the regulation of a number of cell signaling/gene regula-
tory modules including MAP kinases, PI3-kinase/Akt, tran-
scription factors AP-1, Nrf-2 and NFB [96-98]. However, 
due to the transient nature of their effects, only a few direct 
targets of ROS/RNS have yet been identified [95]. In this 
regard, studies on the activation of HIF-1 under hypoxia 
have created an excellent framework of understanding the 
role of ROS/RNS in hypoxic signaling. Accumulated evi-
dences suggest that under normoxia, a family of prolyl hy-
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residues on HIF-1. Hydroxylated HIF-1 then binds to von 
Hippel-Lindau (pVHL) tumor suppressor protein that acts as 
an adapter for the E3 ubiquitin ligase. The ubiquitinylated 
HIF-1 is then degradaded by the proteasome [99]. These 
prolyl hydroxylases being dioxygenases requiring oxygen 
(and 2-oxoglutarate) as substrates and ferrous iron (main-
tained by ascorbate) as cofactors, provide the missing link 
between hypoxia, mitochondrial reactive oxygen species 
generation and stabilization of HIF-1 [100, 101]. It is hy-
pothesized that during hypoxia, the life span of otherwise 
transient ubisemiquinone radical (a constituent of the elec-
tron transport chain) is extended and it transfers its electrons 
to molecular oxygen dissolved in the mitochondrial mem-
brane, generating superoxide (O2
.-) radicals [63, 102]. Under 
normal condition O2
.- radical is attenuated by superoxide 
dismutase, but when generated in excess, it escapes this at-
tenuation process and further generates other reactive oxy-
gen/nitrogen species [103]. Prolyl hydroxylases are sensitive 
to ROS generation, though the mechanism is not fully under-
stood as yet. One possibility is that it is due to the oxidative 
inactivation of the associated iron atom. Therefore, under 
hypoxic environment, excess generation of superoxide radi-
cals inactivates prolyl hydroxylases, thereby stabilizing   
HIF-1.  
H. Myocardial Hypoxia and HIF-1 
  As in other tissues, HIF-1 also plays a major role in elic-
iting hypoxic response of the mammalian myocardium [104, 
105]. Mammalian expression of the regulatory () subunit of 
HIF-1 and it modulator, prolyl hydroxylase significantly 
vary from one tissue to another while the presence of HIF-1 
in the hypoxic myocardium has been confirmed by a number 
of laboratories [106–110]. Paradoxically, some studies had 
also documented the abundance of HIF-1 transcripts but not 
the protein in rat myocardium, implying some additional 
mechanisms of stabilizing the HIF-1 subunit [105, 111- 
113]. Nevertheless, in agreement with the proposed role of 
HIF-1 in mediating hypoxic response in the myocardium, 
increased expression of certain bona-fide targets genes like 
that of MCT4 (mediator of lactic acid efflux); BNP (Brain-
type natriuretic Peptide, modulator of hemodynamic function 
and cytoprotection); VEGF (pro-angiogenic factor) and ape-
lin (cardioprotective) have been reported [114-117]. It is thus 
likely that in the myocardium, HIF-1 expression might be 
under more stringent regulation involving factors other than 
oxygen tension alone [118-121]. In agreement, it has re-
cently been reported that acetylcholine can independently but 
additively (to hypoxia) activate HIF-1 in cardiac myocytes 
[122].  
  In view of such evident association of cardiac hypoxia 
and HIF-1 activity, it is imperative that attempts have been 
made for boosting cardiac function by therapeutic modula-
tion of HIF-1 in the ischemic myocardium. We recently 
have demonstrated that mice injected with recombinant ade-
novirus encoding a cardioprotective angiogenic peptide 
PR39 had protection against ischemia-reperfusion injury that 
was abolished by the attenuation of HIF-1 by the expres-
sion of its dominant negative form [123]. Similarly, trans-
genic mice having HIF-1 overexpression had diminished 
infarct size, increased capillary density and enhanced VEGF 
and iNOS expression following myocardial infarction [124]. 
Also, activation of HIF-1 by pharmacological or siRNA me-
diated inhibition of prolyl hydroxylase resulted in significant 
reduction in myocardial infarct size and expression of 
chemokines like MIP-2, KC, monocyte chemoattractant pro-
tein-1 and ICAM-1, implicating HIF 1 in modulating I/R-
associated cardiac inflammatory responses [125]. 
I. Myocardial Redox Homeostasis and HIF-1 
  It has long been documented that myocardial ischemia-
reperfusion leads to oxidative stress [126-128].  During 
ischemia, decreased respiration leads to reduced electron 
transport, causing electron leakage and O2
.- generation in the 
mitochondria. Following reperfusion, NO is generated that 
interacts with O2
.- ions, producing highly reactive peroxyni-
trite [103, 129]. A group of enzymes and low molecular 
weight peptides viz., thioredoxin and glutaredoxin oxi-
doreductases play a key role in restoring protein thiols under 
oxidative stress [103, 126-128, 130-132]. Thioredoxin and 
glutaredoxin are capapable of acting upon a wide range of 
oxidized proteins, restoring their thiols and thereby maintain-
ing intracellular redox homeostasis, especially in the mito-
chondrial electron transport system [133, 134]. Since HIF-1 
is activated by reactive oxygen species while thioredoxins 
are involved in maintaining the redox equilibrium, it is likely 
that the later might play a critical role in modulating HIF-1 
in heart in heart (and other tissues). However, our current 
knowledge about modulation of HIF activities by thiore-
doxin is quite sporadic. As an example, according to one 
study, overexpression of thioredoxin-1 in human breast car-
cinoma MCF-7 cells results in a significant increase in HIF-
1 protein (but not RNA) levels under both normoxic and 
hypoxic conditions [135]. In a more recent study, overex-
pression of thioredoxin 2 (mitochondria-located) diminished 
HIF-1 accumulation while that of thioredoxin 1 (cytosolic) 
enhanced it. Further analysis suggested that thioredoxins 
affected the translation of HIF-1 while a mitochondria spe-
cific antioxidant MitoQ reversed the thioredoxin 2 mediated 
accumulation of HIF-1, thereby indicating a complex role 
of reactive oxygen species in this process [136]. Taken to-
gether, the precise regulation of redox equilibrium and HIF-1 
activity in heart is an emerging area and it is likely that com-
ing days will shed more light on to it.  
J. Hypoxic Preconditioning and HIF-1 
  Ischemic preconditioning (IP) is a phenomenon where 
brief repetitive cycles of ischemia-reperfusion render the 
myocardium more resistant towards subsequent ischemic 
insult. Although biochemistry, pharmacology and molecular 
biology of IP have been extensively investigated, the contri-
bution of HIF-1 in this process is largely unexplored. How-
ever, accumulating evidences suggest active involvement of 
HIF-1 in mediating the preconditioning response [137]. In 
rat, administration of cobalt chloride, a hypoxic mimetic, 
activates HIF-1 followed by cardioprotection [138]. In 
mouse, cardio-protection induced by intermittent hypoxia is 
attenuated upon targeted inactivation of HIF-1 gene, which 
then can be restored by erythropoietin, a known target of 
HIF-1 [139]. Further, ischemic preconditioning in rat heart 
enhances VEGF gene expression and angiogenesis, hall-
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ing, young male rats show upregulation of a battery of genes 
including  hif-1 and its target vegf [141]. Taken together, 
HIF-1 is likely to be a major contributor towards IP and 
might be considered for future therapeutic induction of pre-
conditioning effect in the myocardium. 
K. Conclusions and Future Perspective 
  Our interest in cellular and organismal oxygen sensing 
attained further height when the criticality of oxygen levels 
in the etiology diseases like cancer, cardiac ischemia and 
stroke became apparent. Although our present knowledge 
about hypoxic response were largely derived form the 
framework of tumor angiogenesis, parallel progress has also 
been made in the context of ischemic and infracted myocar-
dium (Fig. 1). However, whether hypoxic responses are tis-
sue differential or not and if so, to what extent, is not clear as 
yet [142]. In this context, certain unexpected observations 
deserve special attention. In a recent study, adult mice with 
late-stage brain specific deletion of HIF-1 showed protec-
tion from acute hypoxia induced cell death, suggesting more 
divergent role(s) of HIF-1 (or redundant roles of HIF-2/3) 
than originally anticipated [143]. It is thus expected that 
similar analysis in the myocardium might further enhance 
our knowledge about the mechanism of hypoxic response in 
a tissue specific context. Another area of potential impor-
tance (and future debate) is the precise role of ROS in medi-
ating oxygen sensing and eliciting the hypoxic response. 
Although a critical role of mitochondrial ROS in modulating 
prolyl hydroxylase activity and stability of HIF-1 is now 
generally accepted, the precise mechanism of ROS genera-
tion and its difference from those generated under other oxy-
gen associated setups like hyperoxia, preconditioning etc. is 
yet to be deciphered [7, 63, 144]. Finally, further study on 
the additional mechanisms of hypoxic response such as 
translational control and post-translational modification of 
signaling kinases will contribute towards a comprehensive 
understanding and therapeutic intervention of ischemic heart 
diseases [66, 145].  
ABBREVIATIONS 
ATP  =  Adenosine mono phosphate 
AMP Kinase  =  AMP-activated protein kinase  
AP-1 =  Activator  protein-1 
bHLH =  Basic-helix-loop-helix 
BNP  =  Brain natriuretic peptide 
FRET  =  Fluorescence resonance energy transfer 
HIF-1  =  Hypoxia inducible factor 1 
I/R =  Ischemia-reperfusion 
ICAM-1  =  Intercellular cell adhesion molecule 
IGF  =  Insulin like growth factor 
IL-6 =  Interleukin  6 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (1). Schematic representation of hypoxic response by HIF-1: Upper panel: Under normoxic condition, electron transport chain effi-
ciently reduces oxygen and generates ATP. Also, available oxygen is used by prolyl hydroxylase to hydroxylate HIF-1. Hydroxylated HIF-
1 then binds to pVHL followed by ubiqutinylation and degradation by proteasome. Lower panel: Under hypoxic condition, electron trans-
port is perturbed leading to O2
. generation. Reduced oxygen supply and to O2
. inhibit prolyl hydroxylase activity leading to the stabilization 
of HIF-1. HIF-1 then dimerize with HIF-1, binding to its target HRE and activating a battery of hypoxia responsive genes with diverse 
physiological consequences as shown.  270    Current Cardiology Reviews, 2010, Vol. 6, No. 4  Goswami and Das 
iNOS  =  Inducible nitric oxide synthase 
IP =  Ischemic  preconditioning 
MAP Kinase  =  Mitogen activated protein kinase 
MCT4 =  Monocarboxylate  transporter  4 
MIP-2  =  Macrophage Inflammatory Protein-2 
Mn-SOD =  Superoxide  dismutase 
NADPH  =  Nicotinamide adenine dinucleotide  
phosphate 
NCX  =  Neural crest homeobox 
NFB =  Nuclear  factor-kappa  B 
NO =  Nitric  oxide 
PAS =  Per/Arnt/Sim 
PI3 Kinase  =  Phosphoinositide 3-kinase 
RNS =  Reactive  nitrogen  species 
ROS  =  Reactive oxygen species 
RyR =  Ryanodine  receptors 
VEGF  =  Vascular endothelial growth factor 
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